Those include studies reporting stimulation of PEPCK expression by short-chain FAs in hepatoma cells and in primary hepatocytes, as well as by mid-, and long-chain FAs in primary hepatocytes [17,25]. Here, PCK2 is linked to hepatocellular carcinoma.